Vapor Inhaler Inhalant
Product Images NDC 41163-031

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vapor Inhaler (NDC 41163-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supervalu Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (198 mg Blister Pack Label)

Packaging label for Equaline Vapor Inhaler nasal decongestant containing levmetamfetamine 50 mg per inhaler. The label states it provides temporary relief of nasal congestion due to colds, hay fever, and upper respiratory allergies. Distributed by Supervalu Inc., the label includes directions, warnings, inactive ingredients, and a tamper-evident notice. Net weight is 0.07 oz (198 mg).*

FDA Label Image

Principal Display Panel (198 mg Blister Pack Label)

Label for Equaline Vapor Inhaler nasal decongestant with levmetamfetamine 50 mg per inhaler. The product is a nasal inhalant distributed by Supervalu Inc., Eden Prairie, MN. The label includes usage instructions, warnings, inactive ingredients, and a tamper-evident perforated tube label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.